Cargando…

Immune Checkpoints in Solid Organ Transplantation

SIMPLE SUMMARY: The immune system spontaneously recognizes and destroys foreign cells and organs when grafted into a genetically different individual. Organ transplantation is only successful because of the use of life-long immunosuppressive medications, which comes at the cost of severe toxicities....

Descripción completa

Detalles Bibliográficos
Autores principales:	Del Bello, Arnaud, Treiner, Emmanuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604300/ https://www.ncbi.nlm.nih.gov/pubmed/37887068 http://dx.doi.org/10.3390/biology12101358

Ejemplares similares

Adaptive lymphocyte profile analysis discriminates mild and severe forms of COVID-19 after solid organ transplantation
por: Del Bello, Arnaud, et al.
Publicado: (2021)

Immune checkpoint inhibitors for solid organ transplant recipients: clinical updates
por: Kawashima, Shun, et al.
Publicado: (2022)

The CD226/TIGIT axis is involved in T cell hypo-responsiveness appearance in long-term kidney transplant recipients
por: Del Bello, Arnaud, et al.
Publicado: (2022)

Can the COVID-19 Pandemic Improve the Management of Solid Organ Transplant Recipients?
por: Del Bello, Arnaud, et al.
Publicado: (2022)

Effectiveness of Immune Checkpoint Inhibitors in Transplant Recipients with Progressive Multifocal Leukoencephalopathy
por: Medrano, Chloé, et al.
Publicado: (2019)

From Immune Dysregulations to Therapeutic Perspectives in Myelodysplastic Syndromes: A Review
por: Comont, Thibault, et al.
Publicado: (2021)

Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients
por: Kamar, Nassim, et al.
Publicado: (2021)

Infectious complications of immune checkpoint inhibitors in solid organ malignancies
por: Ross, Justine Abella, et al.
Publicado: (2021)

Macrophages in solid organ transplantation
por: Jiang, Xinguo, et al.
Publicado: (2014)

B Cell Immunity in Solid Organ Transplantation
por: Karahan, Gonca E., et al.
Publicado: (2017)

Immune Checkpoint Inhibitors for Solid Tumors in the Adjuvant Setting: Current Progress, Future Directions, and Role in Transplant Oncology
por: Abboud, Karen, et al.
Publicado: (2023)

Tuberculosis in Solid Organ Transplantation
por: Alizadeh, Afshin Mohammad, et al.
Publicado: (2016)

Allograft rejection following immune checkpoint inhibitors in solid organ transplant recipients: A safety analysis from a literature review and a pharmacovigilance system
por: Cui, Xiangli, et al.
Publicado: (2022)

Editorial: “The Role of Immune Checkpoint Molecules in Solid and Hematopoietic Stem Cell Transplantation”
por: Kordelas, Lambros, et al.
Publicado: (2021)

Clinical immune-monitoring strategies for predicting infection risk in solid organ transplantation
por: Fernández-Ruiz, Mario, et al.
Publicado: (2014)

Cryptosporidium infection in solid organ transplantation
por: Florescu, Diana F, et al.
Publicado: (2016)

Regulatory T cells in solid organ transplantation
por: Atif, Muhammad, et al.
Publicado: (2020)

Viral Enteritis in Solid-Organ Transplantation
por: Abbas, Anum, et al.
Publicado: (2021)

Increasing cure rates of solid tumors by immune checkpoint inhibitors
por: Ma, Weijie, et al.
Publicado: (2023)

Combined PARP Inhibition and Immune Checkpoint Therapy in Solid Tumors
por: Peyraud, Florent, et al.
Publicado: (2020)

Existing and Emerging Biomarkers for Immune Checkpoint Immunotherapy in Solid Tumors
por: Arora, Sanjeevani, et al.
Publicado: (2019)

Dendritic Cell-Based Approaches for Therapeutic Immune Regulation in Solid-Organ Transplantation
por: Vassalli, Giuseppe
Publicado: (2013)

Biomarkers in solid organ transplantation: establishing personalized transplantation medicine
por: Roedder, Silke, et al.
Publicado: (2011)

Assessment of 4 Doses of SARS-CoV-2 Messenger RNA–Based Vaccine in Recipients of a Solid Organ Transplant
por: Kamar, Nassim, et al.
Publicado: (2021)

Graft microvascular disease in solid organ transplantation
por: Jiang, Xinguo, et al.
Publicado: (2014)

Alemtuzumab induction therapy in solid organ transplantation
por: Friend, Peter J
Publicado: (2013)

Growth following solid organ transplantation in childhood
por: Fine, Richard N.
Publicado: (2014)

Pneumocystis Pneumonia in Solid-Organ Transplant Recipients
por: Iriart, Xavier, et al.
Publicado: (2015)

Histoplasmosis and Blastomycosis in Solid Organ Transplant Recipients
por: Kauffman, Carol A., et al.
Publicado: (2015)

Respiratory Viruses in Solid Organ Transplant Recipients
por: Bitterman, Roni, et al.
Publicado: (2021)

Repurposing drugs for solid tumor treatment: focus on immune checkpoint inhibitors
por: Liu, Qingxu, et al.
Publicado: (2023)

Therapeutic Monoclonal Antibodies Targeting Immune Checkpoints for the Treatment of Solid Tumors
por: Gravbrot, Nicholas, et al.
Publicado: (2019)

Heterologous Immunity of Virus-Specific T Cells Leading to Alloreactivity: Possible Implications for Solid Organ Transplantation
por: Karahan, Gonca E., et al.
Publicado: (2021)

New Directions for Rabbit Antithymocyte Globulin (Thymoglobulin(®)) in Solid Organ Transplants, Stem Cell Transplants and Autoimmunity
por: Mohty, Mohamad, et al.
Publicado: (2014)

Humoral and Cellular Immune Responses of Solid Organ Transplant Patients on Belatacept to Three Doses of mRNA-Based Anti-SARS-CoV-2 Vaccine
por: Abravanel, Florence, et al.
Publicado: (2022)

PD 1 checkpoint inhibition in solid organ transplants: 2 sides of a coin – case report
por: Goldman, Jonathan W., et al.
Publicado: (2018)

Predictive Factors for Humoral Response After 2-dose SARS-CoV-2 Vaccine in Solid Organ Transplant Patients
por: Marion, Olivier, et al.
Publicado: (2021)

Primary Care of the Solid Organ Transplant Recipient
por: Ruzgar, Nensi Melissa, et al.
Publicado: (2021)

An overview of COVID-19 in solid organ transplantation
por: Bartelt, Luther, et al.
Publicado: (2022)

Hydrogen: Potential Applications in Solid Organ Transplantation
por: Yang, Fuxun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j8enfgerkqen0tn80vgbvbamqr